Alzheimer's disease

Alzheimer's disease, whose factors are still poorly understood, still has no effective treatment.  However, a hypothesis around the role of the intestinal microbiota is emerging, sparking hope for new therapeutic avenues.

Alzheimer's disease, which affects more than 35 million people around the world, is associated with memory loss, language and comprehension problems, attention and concentration problems, apraxia (loss of dexterity), and, in some cases, agnosia (problems recognizing objects or faces). Added to these cognitive symptoms, which worsen over time, are behavioral symptoms such as anxiety, apathy, irritability, sleep problems, disinhibition, and agitation.

Causes still unknown

Several genetic and environmental risk factors have been identified for the disease: hypertension, hypercholesterolemia, smoking, sedentary lifestyle, unbalanced diet, and lack of cognitive stimulation, among others. Lesions in the brain are also a well-known component of the disease, particularly the accumulation of amyloid beta plaques and neuron degeneration. However, the causes of the disease have yet to be clearly determined.

The hypothesis of intestinal microbiota

Researchers are considering whether the intestinal microbiota is involved in Alzheimer’s disease: certain proteins (amyloid peptides) produced by “negative” bacteria in the intestinal flora may favor the development of the disease. Conversely, “beneficial” bacteria may play a protective role, by slowing the formation of amyloid plaques.

Break the therapeutic deadlock

Intestinal microbiota could represent a new avenue for therapeutic research, as no current curative therapy exists for Alzheimer’s disease. Only a few medications lessen symptoms, and their effectiveness is very limited. Some researchers are, therefore, considering carrying out future work on the disease via the microbiota, through dietary changes or by ingesting probiotics.

Diseases related to the nervous system

  • Parkinson's disease

    Parkinson’s disease is the second most common neurodegenerative disease in France. It progressively destroys the dopamine neurons in the bra...
    Voir
  • Autism-spectrum disorders

    Autism-spectrum disorders (ASDs) refer to the collection of neurobiological diseases that affect social interactions. They may have a gastro...
    Voir
  • Anxiety disorders

    Certain anxiety disorders, which a great number of people suffer from, may be linked to activity in the gastrointestinal microbiota through ...
    Voir
  • Mood disorders

    Depression and bipolar disorder indicate a mood disorder. Beyond classic psychiatric treatments, research is in progress to evaluate the imp...
    Voir
  • Schizophrenia

    Chronic inflammation in the brain is suspected in schizophrenia. Disruptions in the gastrointestinal microbiota and the immune system may a...
    Voir